DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.
Rouphael NG, Morgan C, Li SS, Jensen R, Sanchez B, Karuna S, Swann E, Sobieszczyk ME, Frank I, Wilson GJ, Tieu HV, Maenza J, Norwood A, Kobie J, Sinangil F, Pantaleo G, Ding S, McElrath MJ, De Rosa SC, Montefiori DC, Ferrari G, Tomaras GD, Keefer MC; HVTN 105 Protocol Team and the NIAID HIV Vaccine Trials Network.
Rouphael NG, et al. Among authors: tieu hv.
J Clin Invest. 2019 Nov 1;129(11):4769-4785. doi: 10.1172/JCI128699.
J Clin Invest. 2019.
PMID: 31566579
Free PMC article.
Clinical Trial.